Chengdu Easton Biopharmaceuticals Co., Ltd. 688513.SS Stock
Chengdu Easton Biopharmaceuticals Co., Ltd. Price Chart
Chengdu Easton Biopharmaceuticals Co., Ltd. 688513.SS Financial and Trading Overview
Contents
- Chengdu Easton Biopharmaceuticals Co., Ltd. Price Chart
- Chengdu Easton Biopharmaceuticals Co., Ltd. 688513.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Chengdu Easton Biopharmaceuticals Co., Ltd.
- Q&A For Chengdu Easton Biopharmaceuticals Co., Ltd. Stock
| Chengdu Easton Biopharmaceuticals Co., Ltd. stock price | 59.63 CNY |
| Previous Close | 53.19 CNY |
| Open | 53.04 CNY |
| Bid | 53.12 CNY x N/A |
| Ask | 53.18 CNY x N/A |
| Day's Range | 52.75 - 53.36 CNY |
| 52 Week Range | 47.62 - 65.88 CNY |
| Volume | 152.19K CNY |
| Avg. Volume | 410.7K CNY |
| Market Cap | 6.38B CNY |
| Beta (5Y Monthly) | -0.171027 |
| PE Ratio (TTM) | 25.175356 |
| EPS (TTM) | 2.03 CNY |
| Forward Dividend & Yield | 0.56 (1.06%) |
| Ex-Dividend Date | May 23, 2023 |
| 1y Target Est | N/A |
688513.SS Valuation Measures
| Enterprise Value | 5.12B CNY |
| Trailing P/E | 25.175356 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.4087825 |
| Price/Book (mrq) | 2.5457683 |
| Enterprise Value/Revenue | 4.343 |
| Enterprise Value/EBITDA | 22.092 |
Trading Information
Chengdu Easton Biopharmaceuticals Co., Ltd. Stock Price History
| Beta (5Y Monthly) | -0.171027 |
| 52-Week Change | 7.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 65.88 CNY |
| 52 Week Low | 47.62 CNY |
| 50-Day Moving Average | 56.61 CNY |
| 200-Day Moving Average | 57.27 CNY |
688513.SS Share Statistics
| Avg. Volume (3 month) | 410.7K CNY |
| Avg. Daily Volume (10-Days) | 257.62K CNY |
| Shares Outstanding | 120.09M |
| Float | 47.19M |
| Short Ratio | N/A |
| % Held by Insiders | 60.29% |
| % Held by Institutions | 7.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.56 |
| Trailing Annual Dividend Yield | 1.05% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.3697 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 21.51% |
| Operating Margin (ttm) | 14.23% |
| Gross Margin | 82.72% |
| EBITDA Margin | 19.65% |
Management Effectiveness
| Return on Assets (ttm) | 3.52% |
| Return on Equity (ttm) | 10.45% |
Income Statement
| Revenue (ttm) | 1.18B CNY |
| Revenue Per Share (ttm) | 9.81 CNY |
| Quarterly Revenue Growth (yoy) | 3.30% |
| Gross Profit (ttm) | 1.17B CNY |
| EBITDA | 231.86M CNY |
| Net Income Avi to Common (ttm) | 253.7M CNY |
| Diluted EPS (ttm) | 2.11 |
| Quarterly Earnings Growth (yoy) | 13.40% |
Balance Sheet
| Total Cash (mrq) | 1.36B CNY |
| Total Cash Per Share (mrq) | 11.34 CNY |
| Total Debt (mrq) | 124.65M CNY |
| Total Debt/Equity (mrq) | 4.97 CNY |
| Current Ratio (mrq) | 3.191 |
| Book Value Per Share (mrq) | 20.866 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 147.65M CNY |
| Levered Free Cash Flow (ttm) | -172860736 CNY |
Profile of Chengdu Easton Biopharmaceuticals Co., Ltd.
| Country | China |
| State | N/A |
| City | Chengdu |
| Address | No.8, Xiyuan Avenue |
| ZIP | 611731 |
| Phone | 86 28 6758 5121 |
| Website | https://www.eastonpharma.cn |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1323 |
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.
Q&A For Chengdu Easton Biopharmaceuticals Co., Ltd. Stock
What is a current 688513.SS stock price?
Chengdu Easton Biopharmaceuticals Co., Ltd. 688513.SS stock price today per share is 59.63 CNY.
How to purchase Chengdu Easton Biopharmaceuticals Co., Ltd. stock?
You can buy 688513.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Chengdu Easton Biopharmaceuticals Co., Ltd.?
The stock symbol or ticker of Chengdu Easton Biopharmaceuticals Co., Ltd. is 688513.SS.
Which industry does the Chengdu Easton Biopharmaceuticals Co., Ltd. company belong to?
The Chengdu Easton Biopharmaceuticals Co., Ltd. industry is Biotechnology.
How many shares does Chengdu Easton Biopharmaceuticals Co., Ltd. have in circulation?
The max supply of Chengdu Easton Biopharmaceuticals Co., Ltd. shares is 120.09M.
What is Chengdu Easton Biopharmaceuticals Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Chengdu Easton Biopharmaceuticals Co., Ltd. PE Ratio is 29.37438600 now.
What was Chengdu Easton Biopharmaceuticals Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Chengdu Easton Biopharmaceuticals Co., Ltd. EPS is 2.03 CNY over the trailing 12 months.
Which sector does the Chengdu Easton Biopharmaceuticals Co., Ltd. company belong to?
The Chengdu Easton Biopharmaceuticals Co., Ltd. sector is Healthcare.
Stocks Related By Sector
- Harbin Pharmaceutical Group Co., Ltd. 600664.SS Stock
- Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Stock
- Cisen Pharmaceutical Co., Ltd. 603367.SS Stock
- Beijing Chunlizhengda Medical Instruments Co., Ltd. 688236.SS Stock
- Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 688621.SS Stock